There are arguments both for and against making vaccination compulsory.
The Dow Jones Industrial Average has broken the 30,000 level for the first time. The significance of the event was marked by President... Read More... The...
The Dow Jones is closing in on its best month since 1987 after exceeding 30,000 points for the first time. Is it time to collect profits?
OIL There are two main drivers behind the oil price rally of the last few weeks. The first and main... The post Daily market commentary: The...
Investors cheer Yellen appointment, transition process Asia Pacific markets are a sea of green today after Wall Street leapt on the global recovery trade, powered by...
Head of WHO Suggests COVID Restrictions Will Continue Even After Vaccine Tyler Durden Wed, 11/25/2020 - 05:00 Authored by Paul Joseph Watson via Summit News, The...
Vaccines are being touted as taking seven to ten years to develop. But you shouldn't be worried that COVID vaccines only took less than a year.
AstraZeneca’s research chief has said that the more effective dosing regimen of its coronavirus vaccine was discovered by The post ‘Mistake’ led to AZ’s more effective...
Equity markets in bullish mood ahead of Thanksgiving The move from defensive to growth positioning accelerated overnight, stock markets and oil jumped, the dollar fell, and...
Escobar: Flying Dragon, Crashing Eagle Tyler Durden Wed, 11/25/2020 - 00:05 Authored by Pepe Escobar via The Asia Times, Four geoeconomic summits compressed in one week...
Managing Shipping Budgets in 2021: The Old Normal, the New Normal, or the Unknown? Q3 2020 hedge fund letters, conferences and more As they plan their...
U.S. officials plan to release 6.4 million Covid-19 vaccine doses nationwide in an initial distribution after the first one is cleared by regulators for emergency use.
The world’s largest asset manager is impressed with the market’s recent gains, and it has made that sentiment clear by upgrading US stocks. In its recent...
Managing Shipping Budgets in 2021: The Old Normal, the New Normal, or the Unknown? Q3 2020 hedge fund letters, conferences and more As they plan their...
With lockdowns going into effect all over the country again due to the surge in COVID cases, employers all over the country are trying to figure out what to do...
Genentech’s influenza treatment Xofluza (baloxavir marboxil) was granted approval by the U.S. Food and Drug Administration for use in people 12 years and older, making it...
In a report on current market conditions – and the strategic view going forward – JPMorgan’s Marko Kolanovic sees plenty of reasons for optimism. Kolanovic sees...
Commenting on the announcement of a COVID-19 vaccine by Russia and today’s trading, Gorilla Trades strategist Ken Berman said: Q3 2020 hedge fund letters, conferences and...
Presidential transition moves ahead Wall Street is increasingly betting on cyclicals now that the Trump administration has given the green light to the formal transition process...
U.S. Surgeon General Jerome Adams pleaded with Americans to grasp “the severity of the moment” and remain vigilant against the coronavirus pandemic, as record hospitalizations pushed...
Will test a number of promising treatments in urgently needed focus on mild and moderate cases Credit: Kenny Mbala-DNDi NAIROBI/KINSHASA/GENEVA – 24 NOVEMBER 2020 Thirteen African...
Lawmakers may not appear very serious or do not feel the need of sending out another round of stimulus checks. However, those with more expertise on...
ValueWalk’s Raul Panganiban interviews Shree Viswanathan, founder and sole employee of SVN Capital. In this part, Shree discusses if there room for growth, his thoughts on...
The United Nations recently asked a group of experts across the world to recommend ways to persuade people to take a COVID-19 vaccine. Here is a...
As Oil Soars, Former NHL Player Turned Hedge Fund Manager Says "Inevitable" It Will Go Higher Tyler Durden Tue, 11/24/2020 - 10:58 Update (1100ET): WTI just...
EUR/USD rallied today thanks to the better-than-expected macroeconomic data released in Germany as well as persisting optimism among traders caused by the good news about the coronavirus vaccine development. The currency pair has lost a significant...
We have recently written a couple of posts about the "exuberance" that has invaded the market since the election. Such is often seen near short- to...
The United Nations recently asked a group of experts across the world to recommend ways to persuade people to take a COVID-19 vaccine. Here is a...
Agilent Technologies shares were down 3.6% in pre-market trading on Tuesday despite the company reporting better-than-anticipated results for the fourth quarter of FY20 (ended Oct. 31)....
People of color & those with lower incomes or education levels less likely to say they’ll seek vaccination against a disease that’s high risk for older...